Methods and compositions for the repair and/or regeneration of damaged myocardium
Methods, compositions, and kits for repairing damaged myocardium and/or myocardial cells including the administration of cytokines are disclosed and claimed.
1. A method of restoring functional and structural integrity to damaged myocardium in a subject in need thereof comprising forming multiple spaced deposits of at least one cytokine from storage areas of resident adult cardiac stem cells in the subject's heart to a border zone of the damaged myocardium, thereby generating a chemotactic gradient sufficient to mobilize said resident adult cardiac stem cells to the damaged myocardium, wherein the functional and structural integrity of the damaged myocardium is at least partially restored following the mobilization of said adult cardiac stem cells to the area of damaged myocardium.
2. The method of claim 1 , wherein said at least one cytokine is selected from the group consisting of stem cell factor, granulocyte monocyte colony stimulating factor, and hepatocyte growth factor.
3. The method of claim 1 , wherein said multiple spaced deposits of said at least one cytokine are of different concentrations.
4. The method of claim 1 , further comprising administering a second cytokine to the subject's heart, wherein the second cytokine induces proliferation of adult cardiac stem cells.
5. The method of claim 4 , wherein the second cytokine is insulin-like growth factor-1.
6. The method of claim 1 , wherein the storage areas of resident adult cardiac stem cells are one or more of the subject's myocardial apex, left atrium, and right atrium.
7. The method of claim 1 , wherein at least four spaced deposits of said at least one cytokine are formed.
8. A biotechnological process of restoring functional and structural integrity to damaged myocardium in a subject comprising administering multiple doses of at least one cytokine between storage areas of resident adult cardiac stem cells in the subject's heart and a border zone of the damaged myocardium, thereby generating a chemotactic gradient sufficient to replicate and migrate said adult cardiac stem cells to the damaged myocardium, wherein the functional and structural integrity of the damaged myocardium is at least partially restored following the migration of said adult cardiac stem cells to the area of damaged myocardium.
9. The biotechnological process of claim 8 , wherein the at least one cytokine is selected from the group consisting of stem cell factor, granulocyte monocyte colony stimulating factor, and hepatocyte growth factor.
10. The biotechnological process of claim 8 , further comprising administering a second cytokine to the subject's heart, wherein the second cytokine induces proliferation of adult cardiac stem cells.
11. The biotechnological process of claim 10 , wherein the second cytokine is insulin-like growth factor-1.
12. The biotechnological process of claim 8 , wherein the storage areas of resident adult cardiac stem cells are one or more of the subject's myocardial apex, left atrium, and right atrium.
13. The method of claim 8 , wherein said multiple doses each contain a different concentration of said at least one cytokine.
14. The method of claim 13 , wherein the different concentrations of said at least one cytokine increase progressively in a direction towards the damaged myocardium.
15. A method of restoring functional and structural integrity to damaged myocardium in a subject in need thereof comprising administering to the subject multiple doses of hepatocyte growth factor and insulin-like growth factor-1 between storage areas of resident adult cardiac stem cells in the subject's heart and a border zone of the damaged myocardium, thereby generating a chemotactic gradient sufficient to cause adult cardiac stem cells resident in the heart to replicate and migrate to the damaged myocardium, wherein the adult cardiac stem cells differentiate into myocytes, smooth muscle cells, and endothelial cells, and wherein at least some of the differentiated adult cardiac stem cells assemble into myocardial tissue and myocardial vessels.
16. The method of claim 15 , wherein the storage areas of resident adult cardiac stem cells are one or more of the subject's myocardial apex, left atrium, and right atrium.
17. The method of claim 15 , wherein said multiple doses each contain a different concentration of hepatocyte growth factor.
18. The method of claim 15 , wherein said multiple doses each contain the same concentration of insulin-like growth factor-1.